Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biospecifics Tech Cp
(NQ:
BSTC
)
88.53
USD
UNCHANGED
Last Price
Updated: 4:21 PM EST, Dec 1, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Biospecifics Tech Cp
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
July 06, 2020
Biotech stocks rebounded in the holiday-shortened week ending July 2as investors reacted to pending clinical trial readouts and ...
Tags
PCVX
Biotech
OBSV
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
July 01, 2020
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular ...
Tags
VIE
Trading Ideas
ALXN
From
Benzinga
SMMV's Holdings Imply 10% Gain Potential
June 22, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
May 29, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ATNX
IBB
HTBX
From
Benzinga
BioSpecifics Reports First Quarter 2020 Financial and Operating Results
May 11, 2020
- 19% year-over-year increase in royalty revenues for XIAFLEX®
From
PR Newswire
BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer
May 11, 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed...
From
PR Newswire
BioSpecifics Adopts Replacement Stockholder Rights Plan
April 10, 2020
Stockholders to Vote on Rights Plan at 2020 Annual Meeting
From
PR Newswire
BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors
April 09, 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed...
From
PR Newswire
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
April 09, 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed...
From
PR Newswire
How The Pieces Add Up: SMMV Targets $35
March 27, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
March 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
NVS
Earnings
ERYP
From
Benzinga
26.4% Return Seen to Date on SmarTrend Biospecifics Tec Call (BSTC)
March 22, 2020
SmarTrend identified a Downtrend for Biospecifics Tec (NASDAQ:BSTC) on February 25th, 2020 at $60.39. In approximately 3 weeks, Biospecifics Tec has returned 26.36% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
March 16, 2020
- 16% year-over-year increase in royalty revenues for XIAFLEX®
From
PR Newswire
BSTC Crosses Below Key Moving Average Level
February 28, 2020
In trading on Friday, shares of Biospecifics Technologies Corp. (BSTC) crossed below their 200 day moving average of $57.09, changing hands as low as $50.75 per share..
Tags
Stocks
From
Market News Video
How The Parts Add Up: EXT Targets $40
February 04, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Biospecifics Technologies (BSTC) Shares Cross Below 200 DMA
January 24, 2020
In trading on Friday, shares of Biospecifics Technologies Corp. (BSTC) crossed below their 200 day moving average of $57.68, changing hands as low as $56.01 per share..
Tags
Stocks
From
Market News Video
19.1% Return Seen to Date on SmarTrend Biospecifics Tec Call (BSTC)
December 16, 2019
SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on November 5th, 2019 at $50.10. In approximately 1 month, Biospecifics Tec has returned 19.09% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
BSTC Makes Bullish Cross Above Critical Moving Average
December 10, 2019
In trading on Tuesday, shares of Biospecifics Technologies Corp. (BSTC) crossed above their 200 day moving average of $59.12, changing hands as high as $59.20 per share..
Tags
Stocks
From
Market News Video
SMLF's Underlying Holdings Imply 12% Gain Potential
November 11, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
BioSpecifics Reports Third Quarter 2019 Financial and Operating Results
November 08, 2019
- 15% year-over-year increase in royalty revenues for XIAFLEX®
From
PR Newswire
Hedge Funds Have Never Been Less Bullish On Diplomat Pharmacy Inc. (DPLO)
November 07, 2019
What is the key hedge fund action surrounding Diplomat Pharmacy Inc.?
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors
October 23, 2019
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX® in...
From
PR Newswire
The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug
October 22, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
NLNK
MRK
News
From
Benzinga
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
October 17, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ...
Tags
ISRG
FULC
DFFN
From
Benzinga
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
October 15, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ...
Tags
ORGS
NKTR
FIXX
From
Benzinga
Biospecifics Technologies is Now Oversold (BSTC)
October 11, 2019
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer
October 10, 2019
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed...
From
PR Newswire
Stocks That Hit 52-Week Lows On Tuesday
October 08, 2019
Tuesday morning saw 277 companies set new 52-week lows. Areas of Significance: Charles Schwab (NYSE: SCHW) was the largest firm ...
Tags
MAANF
Market News
MC
From
Benzinga
How The Pieces Add Up: SMLF Targets $46
October 08, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Stocks That Hit 52-Week Lows On Thursday
October 03, 2019
Before 10 a.m E.T on Thursday, 301 companies hit new 52-week lows. Noteables: 3M (NYSE: MMM) was the biggest company on a ...
Tags
BOSSY
SDRL
LOGM
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.